BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 11045115)

  • 1. [Sensitivity to antibiotics of bacteria from nosocomial infections. Evolution in resuscitation services of military hospitals].
    Garrabé E; Cavallo JD; Brisou P; Chapalain JC; Coué JC; Courrier P; Granic G; Hervé V; Koeck JL; Morillon M; Claude JD; Rouby Y; Teyssou R
    Presse Med; 2000 Sep; 29(27):1497-503. PubMed ID: 11045115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibiotic sensitivity of aerobic gram-negative bacilli isolated from severe infections in 1992: results of a French multicenter study. Groupe d'Etude d'Infections à bacilles à Gram Négatif (GEIGN)].
    Koeck JL; Cavallo JD; Fabre R; Meyran M; Roué R
    Presse Med; 1996 Oct; 25(30):1363-6. PubMed ID: 8958855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of respiratory isolates of Enterobacteriaceae and Staphylococcus aureus in Italy: incidence and trends over the period 1997-1999.
    Fontana R; Lo Cascio G; Ligozzi M; Friscia O; Oldoni T;
    Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):854-63. PubMed ID: 11837636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
    Mendes C; Hsiung A; Kiffer C; Oplustil C; Sinto S; Mimica I; Zoccoli C;
    Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An analysis of resistance of nosocomial infection pathogens isolated from 13 teaching hospitals in 2011].
    Chen HB; Zhao CJ; Wang H; Cao B; Xu XL; Chu YZ; Hu ZD; Zhuo C; Hu BJ; Liu WE; Liao K; Zhang R; Zeng J; Wang Y; Luo YP; Wang ZW; Liu YM; Chen X; Tian B; Su DH; Zhou CM; Zou MX; Guo PH; Zhou HW; Jin Y
    Zhonghua Nei Ke Za Zhi; 2013 Mar; 52(3):203-12. PubMed ID: 23856111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
    Spencer RC
    Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
    Roland RK; Mendes RE; Silbert S; Bolsoni AP; Sader HS
    Braz J Infect Dis; 2000 Oct; 4(5):226-35. PubMed ID: 11063554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance surveillance of bacteria in 1999 in Korea with a special reference to resistance of enterococci to vancomycin and gram-negative bacilli to third generation cephalosporin, imipenem, and fluoroquinolone.
    Lee K; Lee HS; Jang SJ; Park AJ; Lee MH; Song WK; Chong Y;
    J Korean Med Sci; 2001 Jun; 16(3):262-70. PubMed ID: 11447969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
    Wang H; Chen MJ;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.
    Reynolds R; Potz N; Colman M; Williams A; Livermore D; MacGowan A;
    J Antimicrob Chemother; 2004 Jun; 53(6):1018-32. PubMed ID: 15128723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].
    Atilla A; Eroğlu C; Esen S; Sünbül M; Leblebicioğlu H
    Mikrobiyol Bul; 2012 Jan; 46(1):1-8. PubMed ID: 22399165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.
    Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y
    Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
    Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
    Lascols C; Legrand P; Mérens A; Leclercq R; Muller-Serieys C; Drugeon HB; Kitzis MD; Reverdy ME; Roussel-Delvallez M; Moubareck C; Brémont S; Miara A; Gjoklaj M; Soussy CJ
    Int J Antimicrob Agents; 2011 Mar; 37(3):235-9. PubMed ID: 21295447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals.
    Sutherland CA; Nicolau DP
    Clin Ther; 2015 Jul; 37(7):1564-71. PubMed ID: 26088525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Which betalactam antibiotic use as a marker of multiresistance in Pseudomonas aeruginosa?].
    Cavallo JD; Fabre R; Garrabé E;
    Pathol Biol (Paris); 2003 Oct; 51(8-9):460-3. PubMed ID: 14568590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.